[1st experiences with 5-nitro-oxyquinoline in the treatment of chronic urinary tract infection].
作者信息
Schlesinger E, Patsch R, Kraft M
出版信息
Z Urol Nephrol. 1975 Jun;70(6):429-34.
PMID:810992
Abstract
摘要
相似文献
1
[1st experiences with 5-nitro-oxyquinoline in the treatment of chronic urinary tract infection].[5-硝基氧喹啉治疗慢性尿路感染的首次经验]
Z Urol Nephrol. 1975 Jun;70(6):429-34.
2
Oxolinic acid, nalidixic acid and 5Nok in the treatment of urinary tract infections.
Ther Hung. 1978;26(1):20-3.
3
[Treatment of skin tissue losses of different etiologies with 8-oxyquinoline associated with local anesthetics].[8-羟基喹啉联合局部麻醉药治疗不同病因的皮肤组织缺损]
Minerva Chir. 1983;38(13-14):1113-9.
4
[Chronic urinary tract infection and treatment with Nibiol].
Schweiz Med Wochenschr. 1968 Nov 23;98(47):1864-8.
5
[8-hydroxyquinoline derivatives as wide-spectrum chemotherapeutic agents].[8-羟基喹啉衍生物作为广谱化疗药物]
Klin Med (Mosk). 1984 Feb;62(2):133-6.
6
[Experience with the preparation 5-NOK in a clinical trial. I. Microbiological investigation (author's transl].5 - NOK制剂在一项临床试验中的经验。I. 微生物学研究（作者译）
Cesk Epidemiol Mikrobiol Imunol. 1975 Mar;24(2):97-101.
7
[Study of clinical efficacy and safety of long-term cinoxacin therapy of chronic urogenital organ infection].慢性泌尿生殖器官感染长期西诺沙星治疗的临床疗效与安全性研究
Hinyokika Kiyo. 1987 May;33(5):799-805.
8
[Ofloxacin (RU 43280): clinical evaluation in urinary and prostatic infections].
Pathol Biol (Paris). 1986 May;34(5):494-7.
9
10
[Effectiveness of levofloxacin (Tavanik, "Aventis Pharma") in the treatment of complicated infections of the urogenital organs].
Urologiia. 2003 Jan-Feb(1):31-4.
引用本文的文献
1
Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections.硝羟喹啉治疗单纯性尿路感染疗效及耐受性的文献综述与个体患者数据荟萃分析
BMC Infect Dis. 2014 Nov 27;14:628. doi: 10.1186/s12879-014-0628-7.
2
Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.健康志愿者中 250 毫克硝呋太尔与 200 毫克甲氧苄啶针对尿路病原体的尿药浓度和抗菌活性。
Antimicrob Agents Chemother. 2014;58(2):713-21. doi: 10.1128/AAC.02147-13. Epub 2013 Nov 11.
Zotero 插件